| USES AND USE RESTRICTIONS |
| |
|
Grants may support salaries, equipment, supplies, travel, and patient hospitalization as required to perform the research effort. Restrictions or limitations are imposed against the use of funds for entertainment, foreign travel, general-purpose equipment, alterations and renovations, and other items not regularly required for the performance of research. Individual Predoctoral and Postdoctoral National Research Service Awards (NRSAs) are made directly to individuals for research training in specified biomedical shortage areas. Institutional NRSA awards may be made to eligible institutions to enable them to appoint individuals selected by the institution. Certain service and payback provisions may apply to postdoctoral individuals upon termination of the award or termination of the appointment. SBIR Phase I grants (of approximately 6-months' duration) are to establish the technical merit and feasibility of a proposed research effort that may lead to a commercial product or process. Phase II grants are for the continuation of research initiated in Phase I that is likely to result in commercial products or processes. Only Phase I awardees are eligible to apply for Phase II support. Some Phase II awardees may be eligible to apply for funds to continue research for up to three years beyond the original Phase II award. Eligible projects involve assessment and improvement of drugs or devices or propose to conduct preclinical studies of drugs or devices that ultimately require: 1) clinical evaluation and/or 2) approval of a Federal regulatory agency. The product being developed must be one for which Federal regulatory approval (e.g., FDA) is a required step toward commercialization. Prospective applicants are strongly encouraged to contact NIH staff to determine eligibility. STTR Phase I grants (normally of 1-year duration) are to determine the scientific, technical, and commercial merit and feasibility of the proposed cooperative effort that has potential for commercial application. Phase II funding is based on results of research initiated in Phase I and scientific and technical merit and commercial potential of Phase II application. |
See AidPage for more information on:
Heart and Vascular Diseases Research
See grant announcements for:
Heart and Vascular Diseases Research
Federal Money Retriever® GrantGate®
|
|
Tell-a-Friend
